Pharmac Message on Mesalazine Tablets
Posted Wednesday September 3, 2025
From 1 July 2025 Pharmac listed Mesalazine 1600mg tablets, Asacol brand.
Due to the current shortage of mesalazine 400mg tablets please consider prescribing mesalazine 1600mg for patients that are taking a 1600mg dose.
This is a Section 29 (unapproved) medicine.
Additional information can be found here - Mesalazine tablets Pharmac website
Gallery
Related Articles
The European Medical Journal interviews NZSG's Immediate Past President, Professor Catherine Stedman
Monday February 9, 2026
Our Immediate Past President,was interviewed by the European Medical Journal (EMJ) on her career, being the 1st female g...
Meet the NZSG Research Members
Monday February 9, 2026
Come read about the NZSG Researchers and the work they do.
NZSG Clinical Trials Page are NOW LIVE
Monday February 9, 2026
Learn about clinical trials and how to submit yours!